Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 4

1(14.3%)

7Total

N/A(6)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT05990712Phase 4Unknown

The Effect of a Pre-cataract Surgical Ocular Hygiene Regime on Microbial Load, Tear Osmolarity, Dry Eye, and Inflammatory Markers

Role: lead

NCT05766722Not ApplicableUnknown

Feasibility of an Artificial Intelligence Phone Call After Cataract Surgery

Role: lead

NCT05480839Not ApplicableUnknown

Manual Immediately Sequential Bilateral Cataract Surgery (M-ISBCS) vs Refractive Laser-Assisted Immediately Sequential Bilateral Cataract Surgery (ReLA-ISBCS)

Role: lead

NCT04856397Not ApplicableUnknown

Ozurdex in Suboptimal Diabetic Macular Edema Patients

Role: lead

NCT04856670Unknown

Assessing Diabetes Mellitus on Cytokine Analysis and Macular Edema Following FLACS

Role: lead

NCT04683159Not ApplicableUnknown

Brimonidine Tartrate for Pterygium Surgery

Role: lead

NCT04660006Unknown

Diabetic Retinopathy and OCT-A Changes Post-cataract Surgery

Role: lead

NCT04648618Unknown

Obstructive Sleep Apnea and Diabetic Macular Edema Inflammatory Mediators

Role: lead

NCT03597815Unknown

Diabetic Macular Edema - Obstructive Sleep Apnea Relationship Study

Role: lead

NCT04633954Not ApplicableCompleted

Brimonidine for Subconjunctival Hemorrhage From Femtosecond Laser Assisted Cataract Surgery

Role: lead

NCT04623229Not ApplicableCompleted

A Comparison of Patient Perceptions Undergoing Manual Cataract Surgery (MCS) vs Refractive Laser-assisted Cataract Surgery (ReLACS) in First and Second Eyes

Role: lead

All 11 trials loaded